Efficacy of Wavefront-Guided Scleral Lenses in Patients with Corneal Disease

← Back to Clinical Evidence & Case Library

Case SeriesGSLS 2026

Efficacy of Wavefront-Guided Scleral Lenses in Patients with Corneal Disease

Three patients with distinct corneal disease treated with wavefront-guided scleral lenses.

Patient / conditionCorneal disease; keratoconus
Clinical topicsHOA reduction; visual acuity; visual quality

What this clinical resource describes

Three patients with distinct corneal disease treated with wavefront-guided scleral lenses.

What the poster reports

Key finding / clinical takeaway: Compares visual acuity and HOA RMS before and after HOA optimization, illustrating both the overall trend toward improvement and the importance of individual aberration patterns.

This page is a plain-language guide to the clinical resource, not a replacement for the original poster. The PDF below contains the authors’ complete presentation, figures, methods, measurements, and clinical context.

Why this may be relevant

For patients, this resource may be useful when searching for information about corneal disease; keratoconus and persistent visual-quality concerns that may not be fully explained by standard lower-order prescription alone. A qualified eye care professional can determine whether higher-order aberrations are contributing to an individual patient’s symptoms.

For eye care professionals, this resource may help frame clinical questions around hoa reduction; visual acuity; visual quality. Review the original poster for the complete case details before applying any finding to patient care.

Clinical information notice: This page summarizes a clinical poster or study for educational purposes. Individual outcomes vary. It is not a diagnosis or a substitute for evaluation by a qualified eye care professional. The original source should be reviewed for full context and limitations.